Neximmune Probability of Future Pink Sheet Price Finishing Under 9.02

NEXIDelisted Stock  USD 2.43  0.22  9.95%   
Neximmune's future price is the expected price of Neximmune instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Neximmune performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
  
Please specify Neximmune's target price for which you would like Neximmune odds to be computed.

Neximmune Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neximmune for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neximmune can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Neximmune is not yet fully synchronised with the market data
Neximmune has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (32.34 M) with profit before overhead, payroll, taxes, and interest of 0.
Neximmune currently holds about 53.13 M in cash with (31.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.2.
Roughly 17.0% of the company outstanding shares are owned by corporate insiders

Neximmune Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neximmune Pink Sheet often depends not only on the future outlook of the current and potential Neximmune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neximmune's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares OutstandingM
Cash And Short Term Investments4.6 M

Neximmune Technical Analysis

Neximmune's future price can be derived by breaking down and analyzing its technical indicators over time. Neximmune Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neximmune. In general, you should focus on analyzing Neximmune Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Neximmune Predictive Forecast Models

Neximmune's time-series forecasting models is one of many Neximmune's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Neximmune's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Neximmune

Checking the ongoing alerts about Neximmune for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Neximmune help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Neximmune is not yet fully synchronised with the market data
Neximmune has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (32.34 M) with profit before overhead, payroll, taxes, and interest of 0.
Neximmune currently holds about 53.13 M in cash with (31.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.2.
Roughly 17.0% of the company outstanding shares are owned by corporate insiders
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Neximmune Pink Sheet

If you are still planning to invest in Neximmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neximmune's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Transaction History
View history of all your transactions and understand their impact on performance